Abalone Bio develops target-activating antibodies using its Functional Antibody Selection Technology (FAST) platform, which enables the rapid identification of antibody activators for challenging G-protein coupled receptors (GPCRs). This approach addresses the lack of effective therapeutics for key disease targets, providing a solution to the specificity issues associated with existing small molecule drugs.

The startup operates a global payments platform that integrates APIs, automation, and local payment systems to facilitate international transactions. By enabling clients to issue and pay invoices in their preferred currency at mid-market foreign exchange rates, the platform reduces the costs and complexities associated with traditional financial systems.

A financial super app for Indonesia, this platform integrates banking, investment, and payment services into a single interface, utilizing secure APIs for real-time transactions. It addresses the lack of accessible financial tools for the unbanked population, enhancing financial inclusion and enabling users to manage their finances more effectively.

Alif Semiconductor provides Arm‑based 32‑bit microcontrollers and fusion processors that integrate Cortex‑M55/A32 cores, dedicated Ethos‑U55 neural processing units, and extensive on‑die memory, peripherals, and security features. Their aiPM power‑management system enables ultra‑low deep‑sleep currents and selective domain activation, delivering years of battery life while supporting hardware‑accelerated AI/ML workloads up to 40× faster than conventional MCUs.

Alpaca provides a suite of APIs for stock, options, and cryptocurrency trading, enabling developers and businesses to integrate algorithmic trading and investment features into their applications. The platform addresses the need for a streamlined brokerage infrastructure, allowing users to execute trades commission-free while simplifying the development of financial services.

Manufactures fully connected, zero-emission electric motorcycles designed for urban commuting. The ALVA ONE reduces riding costs by up to 80% and offers real-time performance monitoring through a mobile app, providing an efficient and sustainable alternative to traditional motorcycles.

Develops beanless coffee blends by combining molecularly crafted ingredients with sustainably sourced Arabica beans, reducing reliance on traditional coffee cultivation. This approach addresses environmental challenges in coffee production while delivering a taste that outperforms leading coffee chains in blind taste tests.

Bakkt offers a licensed, API‑driven platform that integrates institutional‑grade custody, brokerage‑grade trading, and fiat‑to‑crypto on‑ramp capabilities for enterprises. The service includes multi‑signature cold storage with insurance, low‑latency order routing under 50‑state money‑transmission licenses, and automated AML/KYC compliance, allowing fintechs, neobanks, and institutional investors to embed crypto functionality without building separate infrastructure.

BioLoomics develops monoclonal antibodies for targeted cancer therapies using specialized bioprocessing techniques to enhance therapeutic efficacy and specificity. The company provides treatment options that improve patient outcomes while minimizing adverse side effects in oncology.

The startup provides smart accommodation services through compact, IoT-integrated sleeping pods that offer a quality sleeping experience at an affordable price. This solution caters to millennial travelers seeking convenient and budget-friendly alternatives to traditional lodging.

Bolt.Earth offers a comprehensive network of over 35,000 charging points across India, providing Level 1, Level 2, and Level 3 charging solutions compatible with all types of electric vehicles. The startup addresses the need for accessible and efficient EV charging infrastructure, enabling users to charge their vehicles safely at home, in commercial settings, or on the go.

Brightseed utilizes its Forager® AI platform to identify and map bioactive compounds in plants, revealing their specific health benefits and connections to human biology. The company addresses the challenge of underutilized plant compounds by providing science-backed natural health solutions, such as its Bio Gut Fiber, which supports gut health through pre-clinical bioactive insights.

Calipsa provides cloud-based AI analytics for video surveillance, utilizing frame-based analysis to enhance real-time security and forensic investigations. The platform reduces false alarms by 93% while delivering actionable intelligence from existing camera systems, enabling more efficient security operations across various sectors.

Carmot Therapeutics develops next‑generation GLP‑1 and dual GLP‑1/GIP receptor agonists that use biased signaling to minimize β‑arrestin recruitment, reducing receptor desensitization and extending drug activity. Its pipeline includes a once‑weekly injectable (CT‑388), a Phase 2 GLP‑1/GIP candidate for overweight/obesity with type 1 diabetes (CT‑868), and an oral daily GLP‑1 small‑molecule (CT‑996), all aimed at delivering stronger glycemic control, greater weight loss, and improved tolerability for metabolic disease patients.

Cauldron Ferm utilizes a proprietary hyper-fermentation technology to enable continuous fermentation processes that significantly increase productivity and reduce manufacturing costs by up to 50% compared to traditional fed-batch methods. This technology addresses the challenges of high production costs and capital requirements in biomanufacturing, facilitating the transition from lab-scale to commercial-scale production for precision fermentation products.

The startup develops AI-driven live-cell imaging technology to predict and optimize stem cell differentiation, enabling the scalable manufacture of any cell or tissue in the body. This approach addresses the need for effective stem cell-based therapies for chronic diseases, facilitating data-driven drug development and improving patient outcomes.

Chemify is a platform that digitizes chemistry and chemical discovery by executing chemical code for drug discovery, synthesis, and materials development. This technology accelerates the synthesis of complex molecules and enables the creation of extensive functional libraries, enhancing reproducibility and efficiency in molecular optimization.

Concerto Biosciences converts complex microbial ecology data into effective, microbe-based consumer health products. The company utilizes proprietary kChip experimental platforms and kAI modeling to generate and analyze vast ecological datasets for predictable microbial engineering. This intelligence enables the development of high-performance ingredients for applications in skin health and other chronic conditions.

Copper provides secure cryptocurrency custody through a multi-party computation (MPC) architecture, enabling institutional investors to manage digital assets without exposing them to exchange counterparty risk. Its ClearLoop network facilitates off-exchange settlements, allowing seamless trading on centralized exchanges while maintaining asset security.

Cortical Labs develops biological computing systems that integrate lab-grown human neurons with silicon chips to create hybrid computing platforms. This technology enables more efficient data processing and complex problem-solving capabilities, addressing limitations in traditional computing architectures.

Curie Co engineers enzymes and marine biomaterials to create eco-friendly alternatives to harmful legacy chemicals in consumer products. Their solutions enhance product performance while meeting regulatory standards and consumer demand for sustainable ingredients across personal care, food, and home care industries.

Deepcell provides the REM-I platform, which utilizes label-free imaging, deep learning, and microfluidics for high-dimensional analysis of single-cell morphology. This technology enables researchers to quantitatively characterize cell phenotypes and functions, facilitating advancements in biological research and diagnostics.

Demetrix runs an online marketplace that sources, verifies, and distributes high‑purity, sustainably harvested natural bioactive ingredients. The platform offers a curated catalog with detailed specifications, certificates of analysis, and bulk, temperature‑controlled shipping, streamlining procurement for pharmaceutical, nutraceutical, and cosmetic formulators.

Detect develops a molecular, multiplex diagnostic platform focused on improving women's health conditions. This system delivers fast, accurate, point-of-need results directly in the clinician's office. The initial focus is on providing rapid diagnostics for vaginitis, with ongoing development for sexual and hormonal health solutions.